New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 22, 2014
07:28 EDTTGTXTG Therapeutics added to Focus List at Roth Capital
Roth Capital added TG Therapeutics to the Focus List based on exceptions the remainder of 2104 will be transformational with upcoming data catalysts and improved visibility from the competitive landscape. Shares are Buy rated with a $15 price target.
News For TGTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 11, 2014
13:14 EDTTGTXTG Therapeutics Phase 3 trial highly likely to succed, says Brean Capital
Subscribe for More Information
November 10, 2014
16:26 EDTTGTXTG Therapeutics reports Q3 EPS with items (51c), consensus (32c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use